Scarica l'app Stockscreener
16.47
3.32%
0.53
Pre-mercato:
17.00
0.53
+3.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Amarin Corp Adr Borsa (AMRN) Ultime notizie
Amarin Corporation Plc Sponsored ADR Actuals & Estimates (NASDAQ:AMRN) - TradingView
EH3 Forecast — Price Target — Prediction for 2027 - TradingView
Net income before discontinued operations of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Price to book ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Non-operating income (total) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Current ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Free cash flow per share of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Diluted earnings per share (diluted EPS) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Amarin Corporation Plc Sponsored ADR Revenue Breakdown – DUS:EH3 - TradingView
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - Benzinga
AMRN Technical Analysis | Trend, Signals & Chart Patterns | AMARIN CORP PLC -ADR (NASDAQ:AMRN) - ChartMill
Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Amarin shareholders reject key proposals at annual meeting, limit equity grants - Investing.com
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - TradingView
Amarin (NASDAQ: AMRN) investors curb new share issues and limit equity pay tools - Stock Titan
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales - TradingView
All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy - Yahoo Finance
Amarin (AMRN) Loss Trend Of 24.2% Annually Tests Turnaround Narratives Heading Into Q1 - Sahm
Amarin (NASDAQ:AMRN) Surprises with Revenue Beat but EPS Falls Short Amid Restructuring Costs - ChartMill
Amarin Corp PLC (FRA:EH3) Stock Price, Trades & News - GuruFocus
Amarin Corporation Plc Sponsored ADR Trade Ideas — FWB:EH3 - TradingView
Will Amarin (AMRN) Stock Go Higher | Price at $14.77, Up 0.20%Hot Stock Picks - The Legal Advocate
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz
Amarin Corporation Plc Sponsored ADR Trade Ideas — SWB:EH3 - TradingView
Amarin (NASDAQ: AMRN) details VASCEPA reach, Recordati deal and $70M savings - Stock Titan
Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss - Finviz
Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill
BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights - Finviz
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Finviz
Ex-Amarin CEO Loses Suit Over Ouster After Proxy Fight - Law360
Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com
FDA updates fenofibrate labels to reflect lack of cardiovascular benefit - Investing.com
Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com
Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance
Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Finviz
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance
Which stocks are gapping on Tuesday? - ChartMill
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Finviz
KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail
SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease - Finviz
Kymera Stock Gains on Positive Data on Investigational Dermatitis Drug - Finviz
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Finviz
CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies - Finviz
Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigat - GuruFocus
Global X Aging Population ETF Holdings - Quiver Quantitative
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
China approves VASCEPA to reduce cardiovascular risk - Investing.com
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Top movers in Wednesday's session - ChartMill
Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.
Earnings BeforeStock ScreenerSnapshot - Finviz
Amarin CorpADR (AMRN) News, Articles, Events & Latest Updates - Stocktwits
What is the current Price Target and Forecast for Amarin (AMRN) - Zacks Investment Research
Which stocks have an unusual volume on Friday? - ChartMill
Which stocks are gapping on Wednesday? - ChartMill
Tuesday's session: gap up and gap down stocks - ChartMill
What date does Amarin's (AMRN) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing - Bloomberg.com
0.83%
1.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):